RE: Hot off the press16 Sep 2025 22:13
Thanks Vikr, very clear whats going to happen here. If anyone had any doubts that should have cleared it.
Still very undervalued, in lots of discussions with keen Pharma companies. Funding is not a an issue. We know if share price stays over 10p by end of November they will get over £4m from lanstead, also we have warrants, upfront payments and the milestone payments so that would pretty much give them a good runway for awhile.